← back to search

Barbara Grant

University of Vermont · US
Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CNS Lymphoma Diagnosis and Treatment, and Monoclonal and Polyclonal Antibodies Research.
h-index
19
citations
5,988
works
38
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine 2013cited by 2,247position: middledoi
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
Journal of Clinical Oncology 2012cited by 1,113position: middledoi
The Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Promotes High Response Rate, Durable Remissions, and Is Tolerable in Treatment Naive (TN) and Relapsed or Refractory (RR) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Patients Including Patients with High-Risk (HR) Disease: New and Updated Results of 116 Patients in a Phase Ib/II Study
Blood 2012cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeff P. Sharman · Sarah Cannon3 papers (2012–2013)Richard R. Furman · Cornell University3 papers (2012–2013)John C. Byrd · The University of Texas Southwestern Medical Center2 papers (2012–2013)Ian W. Flinn · Centennial Medical Center2 papers (2012–2013)Susan O’Brien · University of California, Irvine2 papers (2012–2013)Juthamas Sukbuntherng · Pharmacyclics (United States)2 papers (2012–2013)Steven Coutré · Stanford University2 papers (2012–2013)Fong Clow · AbbVie (United States)2 papers (2012–2013)Amy J. Johnson · The Ohio State University2 papers (2012–2013)Eric Hedrick · Biogen (United States)2 papers (2012–2013)Kristie A. Blum · Winship Cancer Institute2 papers (2012–2013)Jan A. Burger · The University of Texas MD Anderson Cancer Center2 papers (2012–2013)Betty Chang · Vyne Therapeutics (United States)2 papers (2012–2013)Joseph J. Buggy · Collaborative Drug Discovery (United States)2 papers (2012–2013)Weiqiang Zhao · Harbin Institute of Technology2 papers (2012–2013)Danelle F. James · Freedom House2 papers (2012–2013)William G. Wierda · The University of Texas MD Anderson Cancer Center2 papers (2012–2013)Jeffrey A. Jones · The Ohio State University2 papers (2012–2013)Nyla A. Heerema · St. Jude Children's Research Hospital2 papers (2012–2013)Sonali M. Smith · Rutgers Cancer Institute1 papers (2012–2012)